Activation of Membrane-Bound Phospholipase D by Protein Kinase C in HL60 Cells: Synergistic Action of a Small GTP-Binding Protein RhoA

1995 ◽  
Vol 211 (1) ◽  
pp. 306-311 ◽  
Author(s):  
K. Ohguchi ◽  
Y. Banno ◽  
S. Nakashima ◽  
Y. Nozawa
1990 ◽  
Vol 271 (3) ◽  
pp. 693-700 ◽  
Author(s):  
J Van der Meulen ◽  
R J Haslam

Rabbit platelets were labelled with [3H]glycerol and incubated with or without phorbol 12-myristate 13-acetate (PMA). Membranes were then isolated and assayed for phospholipase D (PLD) activity by monitoring [3H]phosphatidylethanol formation in the presence of 300 mM-ethanol. At a [Ca2+free] of 1 microM, PLD activity was detected in control membranes, but was 5.4 +/- 0.8-fold (mean +/- S.E.M.) greater in membranes from PMA-treated platelets. Under the same conditions, 10 microM-guanosine 5′-[gamma-thio]triphosphate (GTP[S]) stimulated PLD by 18 +/- 3-fold in control membranes, whereas PMA treatment and GTP[S] interacted synergistically to increase PLD activity by 62 +/- 12-fold. GTP[S]-stimulated PLD activity was observed in the absence of Ca2+, but was increased by 1 microM-Ca2+ (3.5 +/- 0.2-fold and 1.8 +/- 0.1-fold in membranes from control and PMA-treated platelets respectively). GTP exerted effects almost as great as those of GTP[S], but 20-30-fold higher concentrations were required. Guanosine 5′-[beta-thio]diphosphate inhibited the effects of GTP[S] or GTP, suggesting a role for a GTP-binding protein in activation of PLD. Thrombin (2 units/ml) stimulated the PLD activity of platelet membranes only very weakly and in a GTP-independent manner. The actions of PMA and analogues on PLD activity correlated with their ability to stimulate protein kinase C in intact platelets. Staurosporine, a potent protein kinase inhibitor, had both inhibitory and, at higher concentrations, stimulatory effects on the activation of PLD by PMA. The results suggest that PMA not only stimulates PLD via activation of protein kinase C but can also activate the enzyme by a phosphorylation-independent mechanism in the presence of staurosporine. However, under physiological conditions, full activation of platelet PLD may require the interplay of protein kinase C, increased Ca2+ and a GTP-binding protein, and may occur as a secondary effect of the activation of phospholipase C.


1992 ◽  
Vol 44 (1) ◽  
pp. 11-24 ◽  
Author(s):  
P. Dryden ◽  
B. Allen ◽  
S. Wong ◽  
A. Reaney ◽  
T. Merali ◽  
...  

1999 ◽  
Vol 276 (4) ◽  
pp. G915-G923 ◽  
Author(s):  
Fumihiko Nozu ◽  
Yasuhiro Tsunoda ◽  
Adenike I. Ibitayo ◽  
Khalil N. Bitar ◽  
Chung Owyang

We evaluated intracellular pathways responsible for the activation of the small GTP-binding protein Rho p21 in rat pancreatic acini. Intact acini were incubated with or without CCK and carbachol, and Triton X-100-soluble and crude microsomes were used for Western immunoblotting. When a RhoA-specific antibody was used, a single band at the location of 21 kDa was detected. CCK (10 pM–10 nM) and carbachol (0.1–100 μM) dose dependently increased the amount of immunodetectable RhoA with a peak increase occurring at 3 min. High-affinity CCK-A-receptor agonists JMV-180 and CCK-OPE (1–1,000 nM) did not increase the intensities of the RhoA band, suggesting that stimulation of RhoA is mediated by the low-affinity CCK-A receptor. Although an increase in RhoA did not require the presence of extracellular Ca2+, the intracellular Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane- N, N, N′, N′-tetraacetic acid-AM abolished the appearance of the RhoA band in response to CCK and carbachol. The Gq protein inhibitor G protein antagonist-2A (10 μM) and the phospholipase C (PLC) inhibitor U-73122 (10 μM) markedly reduced RhoA bands in response to CCK. The protein kinase C (PKC) activator phorbol ester (10–1,000 nM) dose dependently increased the intensities of the RhoA band, which were inhibited by the PKC inhibitor K-252a (1 μM). The pp60c- src inhibitor herbimycin A (6 μM) inhibited the RhoA band in response to CCK, whereas the calmodulin inhibitor W-7 (100 μM) and the phosphoinositide 3-kinase inhibitor wortmannin (6 μM) had no effect. RhoA was immunoprecipitated with Src, suggesting association of RhoA with Src. Increases in mass of this complex were observed with CCK stimulation. In permeabilized acini, the Rho inhibitor Clostridium botulinum C3 exoenzyme dose dependently inhibited amylase secretion evoked by a Ca2+ concentration with an IC50 of C3 exoenzyme at 1 ng/ml. We concluded that the small GTP-binding protein RhoA p21 exists in pancreatic acini and appears to be involved in the mediation of pancreatic enzyme secretion evoked by CCK and carbachol. RhoA pathways are involved in the activation of PKC and Src cascades via Gq protein and PLC.


Sign in / Sign up

Export Citation Format

Share Document